UVV 8-K SEC Filing Analysis

Latest settled — T+5d

UVV ▲ +3.64% at T+5d

SHORT call ✗ call lost -3.64% · α vs SPY -6.14% · entry $51.87 → $53.76

Next anchor: T+20d in 13d

Currently $53.93 · -3.97% from $51.87 entry (call sign-flipped)

Entry anchored
May 28, 03:59 PM ET
via Databento tick

T+1d

+4.36%

call -4.36% · α -4.10%

$54.13

settled 15d ago

T+5d

+3.64%

call -3.64% · α -6.14%

$53.76

settled 9d ago

T+20d

—

call — · α —

—

in 13d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Universal Corp (UVV) reported Q4 FY2026 GAAP diluted EPS of -$1.73 versus consensus of $0.25, a -792% miss, dragged by a $41.1M non-cash goodwill impairment on the Shanks ingredients operation and $52.0M in tobacco inventory write-downs. Full-year revenue fell 1% to $2.92B and adjusted operating income dropped 13% to $211.3M. Management guided uncommitted tobacco inventories back to target in FY2027 but faces persistent oversupply and weak ingredients demand.

Key Financial Metrics

Free Cash Flow

$80.3M

Gross Margin

13.8%

Actionable Insight

The large GAAP EPS miss combined with a goodwill impairment and elevated inventory write-downs signals structural challenges in the Ingredients segment and a tobacco oversupply cycle. The adjusted EPS miss vs Nasdaq reference ($-0.46 vs $1.08 consensus) confirms the Street was caught off-guard. Monitor the May 29 conference call for details on Shanks turnaround plan and timeline for inventory normalization. FY2027 guidance will be critical — without a clear path to margin recovery, further downside is likely.

Key Facts

Q4 GAAP diluted EPS was -$1.73 vs consensus of $0.25 (-792% miss); adjusted diluted EPS was -$0.46 vs consensus $1.08 (-142.6% miss per Nasdaq reference)
Revenue was $715.2M vs consensus of $587.0M (consensus likely stale — revenue actually rose 2% YoY but below historical Q4 run rate)
Recorded $41.1M non-cash goodwill impairment charge on Universal Ingredients-Shanks unit
Tobacco inventory write-downs of $52.0M for the year, up $32.2M from prior year; uncommitted tobacco inventory at 27% vs target range
Fiscal 2026 adjusted operating income fell 13% to $211.3M; GAAP operating income down 28% to $168.5M
Total debt reduced by $168.7M YoY to $904.3M; net debt rose $28.9M to $845.5M due to cash burn from working capital
Ingredients Operations segment FY revenue up 3% but segment operating income down 74% to $3.2M; Q4 revenue down 7% YoY

Financial Impact

EPS miss of $1.98 vs consensus; $41.1M goodwill impairment and $52.0M inventory write-downs; adjusted operating income down 13% YoY

earningsrevenueoperating incomeinventory valuationgoodwill

Risk Factors

Prolonged tobacco oversupply (27% uncommitted inventory vs target range) could lead to further write-downs
Shanks ingredients operation: slower sales growth, high fixed costs, and tariff headwinds may require additional restructuring
Goodwill impairment may signal further intangible asset impairments in the Ingredients segment
Consumer packaged goods softness and tariff impacts may persist, pressuring Ingredients revenue and margins

Market Snapshot

Exchange

NYSE

Sector

Wholesale-Farm Product Raw Materials

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001628280-26-038822
Document: uvv-20260528.htm	0001628280-26-038822
Document: 0001628280-26-038822-index-headers.html	0001628280-26-038822
Document: 0001628280-26-038822-index.html	0001628280-26-038822
Document: 0001628280-26-038822.txt	0001628280-26-038822
8-K Data (Synthetic)	0001628280-26-038822

US Market Status

Market Closed — Opens Mon (53h 13m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access